	Reproductive and Perinatal Outcomes After Trachelectomy: Vaginal Microbiota and Early Preterm Birth. J Obstet Gynaecol Res Takemura H, Taki M, Okamoto H, Ikeda A, Okunomiya A, Chigusa Y, Mogami H, Horie A, Mandai M. PMID: 42572375 [PubMed - indexed for MEDLINE]
	Pelvic Wandering Spleen Mimicking an Ovarian Germ Cell Tumor. J Obstet Gynaecol Res Mammadova G, Ersak B, K, Çak. PMID: 42572374 [PubMed - indexed for MEDLINE]
	Population Pharmacokinetics and Exposure-Response Analyses of Vepdegestrant, a First-in-Class PROteolysis-TArgeting Chimera Estrogen Receptor Degrader. J Clin Pharmacol Yang DZ, Masters JC, Wang H, Tran L, Zhang Y, Lee KC, Tan W, Jermain B. PMID: 42572241 [PubMed - indexed for MEDLINE]
	Current Advances of Molecular Biomarkers and Liquid Biopsies Techniques in Ovarian Cancer. Cancer Med Zhang J, Shan W, Yu J, Shi H, Xu Q, Shang H. PMID: 42572185 [PubMed - indexed for MEDLINE]
	Randomized phase 2 trial of a PARP inhibitor TSL-1502 in germline BRCA-mutated, HER2-negative locally advanced/metastatic breast cancer. Signal Transduct Target Ther Lan B, Xu F, Sun T, Qiu F, Wang Y, Wang S, Li W, Zhong Y, Wu X, Ouyang Q, Wang K, Mi X, Liu R, Xu B. PMID: 42572030 [PubMed - indexed for MEDLINE]
	Determinants of mammography screening uptake among women attending family health centers in Ankara, TÃ¼rkiye: a cross-sectional study. BMC Health Serv Res Topcu FB, Çetintepe SP, Baysan C, Türk KN, Özkan S. PMID: 42571012 [PubMed - indexed for MEDLINE]
	Retraction Note: Blockage of AMPK-ULK1 pathway mediated autophagy promotes cell apoptosis to increase doxorubicin sensitivity in breast cancer (BC) cells: an in vitro study. BMC Cancer Yu L, Shi Q, Jin Y, Liu Z, Li J, Sun W. PMID: 42571011 [PubMed - in process]
	Long-term results of preoperative hypofractionated chemoradiotherapy for high-risk HER2-positive and triple-negative breast cancer subtypes. Clin Transl Oncol Ciérvide R, Montero Á, García-Aranda M, Valero J, Álvarez B, Chen X, Alonso R, López M, Hernando O, Sánchez E, Rubio C. PMID: 42570990 [PubMed - as supplied by publisher]
	Cross-Spatial-Scale Radiomics for Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter, Interpretable MRI Study. Acad Radiol Wang P, Wang CX, Jie M, Gao X, Sun X, Zhang H, Cao Y, Yin Y, Li F. PMID: 42570910 [PubMed - as supplied by publisher]
	Predicting Breast Cancer with Super-Resolution Ultrasound-Based Radiomics: A Multicenter Retrospective Study. Acad Radiol Xu J, Zheng Y, Jia X, Hua Q, Xia S, Tang B, Xiong S, Zhou X, Hu Q, Hou X, Yao Y, Yang X, Yang L, Lyu J, Li L, Kong Y, Zheng Y, Hua G, Zhang Y, Wu F, Guo W, Tian Y, Dong Y, Shi J, Zhou J. PMID: 42570906 [PubMed - as supplied by publisher]
	The estrogen-integrin Î±vÎ²3 crosstalk in breast cancer: Modulating PD-L1 and immune evasion. Biomed Pharmacother Crawford DR, Yang YN, Liu FC, Lin CM, Yang YSH, Li ZL, Shih YJ, Mo JK, Yao CJ, Lin HY, Wang K. PMID: 42551188 [PubMed - as supplied by publisher]
	Editorial for "Magnetic Resonance Elastography in Breast Cancer: A Prospective Study on Optimal Imaging Frequency Selection and Differentiation of Molecular Subtypes". J Magn Reson Imaging Shi Y. PMID: 42550858 [PubMed - as supplied by publisher]
	Weight Loss Responses to Pharmacotherapy in Breast Cancer Survivors: Results from the Adaptive Nutrition and Exercise Weight loss (A-NEW) Study. Clin Cancer Res Sheng JY, Zahurak ML, Too F, Montanari A, Trost J, Lu M, Lee Y, Parida S, Blackford AL, Sharma D, Laudenslager M, Snyder C, Coughlin JW, Stearns V. PMID: 42550849 [PubMed - as supplied by publisher]
	Right Ventricular Metastasis From Cervical Cancer Treated With Pembrolizumab-Containing Chemotherapy: A Case Report and Literature Review. Am J Case Rep Fukunaga C, Hiranuma K, Hirayama T, Yoshida E, Fujino K, Mizuno S, Inaba H, Saeki H, Terao Y. PMID: 42550800 [PubMed - indexed for MEDLINE]
	Molecular evaluation of residual disease following neoadjuvant chemotherapy in triple negative breast cancer CALGB40603 (Alliance). J Clin Invest Rädler PD, Felsheim BM, Fernandez-Martinez A, Pfefferle AD, Hayward MC, Singh B, Sikov W, Carey LA, Perou CM. PMID: 42550611 [PubMed - as supplied by publisher]
	Mapping the invisible: a Bayesian spatio-temporal analysis of male breast cancer mortality inequalities across Spanish provinces, 1999-2023. Clin Transl Oncol Cayuela L, Pereyra-Rodríguez JJ, Rodríguez-Hernández JC, Machancoses FH, Cayuela A. PMID: 42570166 [PubMed - as supplied by publisher]
	A clinical-radiomics model based on MRI sub-regions of gluteus maximus for recurrence prediction in high-grade serous ovarian cancer. Abdom Radiol (NY) Bi Q, Wang X, Tan J, Dai H, Wu Y, Song Y, Ai C, Zhang H, Wu L. PMID: 42570087 [PubMed - as supplied by publisher]
	Expectations and experiences of yoga in women with breast cancer receiving endocrine therapy: a qualitative study. Support Care Cancer Gür G, Ard, Gumusay O, Can G. PMID: 42570034 [PubMed - indexed for MEDLINE]
	The role of magnetic resonance imaging (MRI) in breast cancer molecular subtypes. Pol J Radiol Xu R, Miao Z, Zuo X, Lu L, Luo P, Li G. PMID: 42569136 [PubMed]
	Retracted: Enhancing diagnostic accuracy in breast cancer: integrating novel machine learning approaches with enhanced image preprocessing for improved mammography analysis. Pol J Radiol Mehrabi M, Salek N. PMID: 42569091 [PubMed]

Articles 1 - 20 / 333399

Page 1 of 16670



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy